Promoting Quality in Drug Manufacturing

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-09-02-2004, Volume 28, Issue 9

FDA is re-engineering the CMC review process for innovator and generic drugs and backing risk-based ICH quality standards.

Related Content:

Process ValidationManufacturingQuality SystemsRegulatory WatchDevelopmentPharmaceutical Technology-09-02-2004
FUJIFILM Diosynth Biotechnologies Completes New Viral Vector Gene Therapy Manufacturing Facility in UK
The European Commission Approves Severe Alopecia Areata Treatment
Continuous Manufacturing is Here to Stay (PDA/FDA Joint Regulatory Conference 2023)